Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes

Autor: Sjoukje van der Hoek, Jeroen V. Koomen, Erik J. M. van Bommel, Charlotte M. Mosterd, Rosalie A. Scholtes, Anne C. Hesp, Jasper Stevens, Daniel H. van Raalte, Hiddo J. L. Heerspink

Publikováno v: van der Hoek, S, Koomen, J V, van Bommel, E J M, Mosterd, C M, Scholtes, R A, Hesp, A C, Stevens, J, van Raalte, D H & Heerspink, H J L 2023, ' Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes ', Journal of personalized medicine, vol. 13, no. 5, 747 . https://doi.org/10.3390/jpm13050747
Journal of personalized medicine, 13(5):747. MDPI AG
Journal of Personalized Medicine; Volume 13; Issue 5; Pages: 747
Journal of personalized medicine, 13(5):747. Multidisciplinary Digital Publishing Institute (MDPI)

Sodium–glucose cotransporter-2 (SGLT2) inhibitors improve markers for renal and cardiovascular outcomes in patients with and without type 2 diabetes (T2D). To assess whether individual differences in plasma drug exposure can explain inter-individua

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59cc313ccc91b0131f6f4169819d073b
https://research.vumc.nl/en/publications/8d520102-a9a8-479e-9f69-9203331b9919